Literature DB >> 15482160

Control of influenza virus infection by immunity to conserved viral features.

Suzanne L Epstein1.   

Abstract

Influenza has circulated among humans for centuries and kills more people than many newly emerging diseases. The present methods for control of influenza are not adequate, especially for dealing with a pandemic. In the face of a rapidly spreading outbreak, a race to isolate the virus and prepare a vaccine would probably not succeed in time to avoid great losses. Thus, additional anti-infection strategies are needed. Broad cross-protection against widely divergent influenza A subtypes is readily achieved in animals by several means of immunization. How does cross-protection work in animals, and can we apply what we have learned about it to induce broad cross-protection in humans?

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15482160     DOI: 10.1586/14787210.1.4.627

Source DB:  PubMed          Journal:  Expert Rev Anti Infect Ther        ISSN: 1478-7210            Impact factor:   5.091


  21 in total

1.  Recombinant parainfluenza virus 5 (PIV5) expressing the influenza A virus hemagglutinin provides immunity in mice to influenza A virus challenge.

Authors:  S Mark Tompkins; Yuan Lin; George P Leser; Kari A Kramer; Debra L Haas; Elizabeth W Howerth; Jie Xu; Mary J Kennett; Russell K Durbin; Joan E Durbin; Ralph Tripp; Robert A Lamb; Biao He
Journal:  Virology       Date:  2007-01-23       Impact factor: 3.616

2.  Generation and testing anti-influenza human monoclonal antibodies in a new humanized mouse model (DRAGA: HLA-A2. HLA-DR4. Rag1 KO. IL-2Rγc KO. NOD).

Authors:  Mirian Mendoza; Angela Ballesteros; Qi Qiu; Luis Pow Sang; Soumya Shashikumar; Sofia Casares; Teodor-D Brumeanu
Journal:  Hum Vaccin Immunother       Date:  2017-12-21       Impact factor: 3.452

3.  Significant impact of sequence variations in the nucleoprotein on CD8 T cell-mediated cross-protection against influenza A virus infections.

Authors:  Weimin Zhong; Feng Liu; Libo Dong; Xiuhua Lu; Kathy Hancock; Ellis L Reinherz; Jacqueline M Katz; Suryaprakash Sambhara
Journal:  PLoS One       Date:  2010-05-11       Impact factor: 3.240

4.  Single-dose mucosal immunization with a candidate universal influenza vaccine provides rapid protection from virulent H5N1, H3N2 and H1N1 viruses.

Authors:  Graeme E Price; Mark R Soboleski; Chia-Yun Lo; Julia A Misplon; Mary R Quirion; Katherine V Houser; Melissa B Pearce; Claudia Pappas; Terrence M Tumpey; Suzanne L Epstein
Journal:  PLoS One       Date:  2010-10-04       Impact factor: 3.240

5.  Recombinant parainfluenza virus 5 expressing hemagglutinin of influenza A virus H5N1 protected mice against lethal highly pathogenic avian influenza virus H5N1 challenge.

Authors:  Zhuo Li; Alaina J Mooney; Jon D Gabbard; Xiudan Gao; Pei Xu; Ryan J Place; Robert J Hogan; S Mark Tompkins; Biao He
Journal:  J Virol       Date:  2012-10-17       Impact factor: 5.103

6.  Infection of HLA-DR1 transgenic mice with a human isolate of influenza a virus (H1N1) primes a diverse CD4 T-cell repertoire that includes CD4 T cells with heterosubtypic cross-reactivity to avian (H5N1) influenza virus.

Authors:  Katherine A Richards; Francisco A Chaves; Andrea J Sant
Journal:  J Virol       Date:  2009-04-22       Impact factor: 5.103

7.  Downregulating viral gene expression: codon usage bias manipulation for the generation of novel influenza A virus vaccines.

Authors:  Steven F Baker; Aitor Nogales; Luis Martínez-Sobrido
Journal:  Future Virol       Date:  2015-06       Impact factor: 1.831

8.  Intranasal vaccination with 1918 influenza virus-like particles protects mice and ferrets from lethal 1918 and H5N1 influenza virus challenge.

Authors:  Lucy A Perrone; Attiya Ahmad; Vic Veguilla; Xiuhua Lu; Gale Smith; Jacqueline M Katz; Peter Pushko; Terrence M Tumpey
Journal:  J Virol       Date:  2009-03-25       Impact factor: 5.103

9.  Heterosubtype neutralizing responses to influenza A (H5N1) viruses are mediated by antibodies to virus haemagglutinin.

Authors:  Jean-Michel Garcia; Stephanie Pepin; Nadège Lagarde; Edward S K Ma; Frederick R Vogel; Kwok H Chan; Susan S S Chiu; J S M Peiris
Journal:  PLoS One       Date:  2009-11-20       Impact factor: 3.240

10.  Acquired heterosubtypic antibodies in human immunity for avian H5N1 influenza.

Authors:  Garry W Lynch; Paul Selleck; John S Sullivan
Journal:  J Mol Genet Med       Date:  2009-12-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.